Prognostic Indicators (TB)

Treatment History Predictive of MDR-TB Development

Published in TB and Outbreaks Week, June 9th, 1997

Previous treatment outcome and current clinical and epidemiologic histories can be used to predict the development of multidrug-resistance in patients undergoing retreatment for tuberculosis, according to a report from the University of California at Berkeley.

Researcher Afranio L. Kritski and colleagues also found these variables to be important predictors of adverse outcomes in retreated patients.

"Our present study suggests that clinical outcomes and the likelihood of development of multidrug-resistant tuberculosis (MDR-TB) may be predicted by grouping previously treated patients into those who abandon treatment or suffer relapse after treatment,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry